Your browser doesn't support javascript.
loading
Reply to T. Shimoi et al and Y. Shimanuki et al.
Mayer, Ingrid A; Zhao, Fengmin; Arteaga, Carlos L; Symmans, William F; Park, Ben H; Burnette, Brian L; Tevaarwerk, Amye J; Garcia, Sofia F; Smith, Karen L; Makower, Della F; Block, Margaret; Morley, Kimberly A; Jani, Chirag R; Mescher, Craig; Dewani, Shabana J; Tawfik, Bernard; Flaum, Lisa E; Mayer, Erica L; Sikov, William M; Rodler, Eve T; Wagner, Lynne I; DeMichele, Angela M; Sparano, Joseph A; Wolff, Antonio C; Miller, Kathy D.
Afiliação
  • Mayer IA; Ingrid A. Mayer, MD, MSCI, Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Fengmin Zhao, PhD, Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA; Carlos L. Arteaga, MD, UT Southwestern Simmons Cancer Center, Dallas, TX; William F. Symmans, M
  • Zhao F; Ingrid A. Mayer, MD, MSCI, Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Fengmin Zhao, PhD, Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA; Carlos L. Arteaga, MD, UT Southwestern Simmons Cancer Center, Dallas, TX; William F. Symmans, M
  • Arteaga CL; Ingrid A. Mayer, MD, MSCI, Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Fengmin Zhao, PhD, Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA; Carlos L. Arteaga, MD, UT Southwestern Simmons Cancer Center, Dallas, TX; William F. Symmans, M
  • Symmans WF; Ingrid A. Mayer, MD, MSCI, Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Fengmin Zhao, PhD, Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA; Carlos L. Arteaga, MD, UT Southwestern Simmons Cancer Center, Dallas, TX; William F. Symmans, M
  • Park BH; Ingrid A. Mayer, MD, MSCI, Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Fengmin Zhao, PhD, Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA; Carlos L. Arteaga, MD, UT Southwestern Simmons Cancer Center, Dallas, TX; William F. Symmans, M
  • Burnette BL; Ingrid A. Mayer, MD, MSCI, Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Fengmin Zhao, PhD, Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA; Carlos L. Arteaga, MD, UT Southwestern Simmons Cancer Center, Dallas, TX; William F. Symmans, M
  • Tevaarwerk AJ; Ingrid A. Mayer, MD, MSCI, Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Fengmin Zhao, PhD, Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA; Carlos L. Arteaga, MD, UT Southwestern Simmons Cancer Center, Dallas, TX; William F. Symmans, M
  • Garcia SF; Ingrid A. Mayer, MD, MSCI, Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Fengmin Zhao, PhD, Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA; Carlos L. Arteaga, MD, UT Southwestern Simmons Cancer Center, Dallas, TX; William F. Symmans, M
  • Smith KL; Ingrid A. Mayer, MD, MSCI, Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Fengmin Zhao, PhD, Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA; Carlos L. Arteaga, MD, UT Southwestern Simmons Cancer Center, Dallas, TX; William F. Symmans, M
  • Makower DF; Ingrid A. Mayer, MD, MSCI, Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Fengmin Zhao, PhD, Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA; Carlos L. Arteaga, MD, UT Southwestern Simmons Cancer Center, Dallas, TX; William F. Symmans, M
  • Block M; Ingrid A. Mayer, MD, MSCI, Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Fengmin Zhao, PhD, Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA; Carlos L. Arteaga, MD, UT Southwestern Simmons Cancer Center, Dallas, TX; William F. Symmans, M
  • Morley KA; Ingrid A. Mayer, MD, MSCI, Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Fengmin Zhao, PhD, Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA; Carlos L. Arteaga, MD, UT Southwestern Simmons Cancer Center, Dallas, TX; William F. Symmans, M
  • Jani CR; Ingrid A. Mayer, MD, MSCI, Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Fengmin Zhao, PhD, Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA; Carlos L. Arteaga, MD, UT Southwestern Simmons Cancer Center, Dallas, TX; William F. Symmans, M
  • Mescher C; Ingrid A. Mayer, MD, MSCI, Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Fengmin Zhao, PhD, Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA; Carlos L. Arteaga, MD, UT Southwestern Simmons Cancer Center, Dallas, TX; William F. Symmans, M
  • Dewani SJ; Ingrid A. Mayer, MD, MSCI, Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Fengmin Zhao, PhD, Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA; Carlos L. Arteaga, MD, UT Southwestern Simmons Cancer Center, Dallas, TX; William F. Symmans, M
  • Tawfik B; Ingrid A. Mayer, MD, MSCI, Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Fengmin Zhao, PhD, Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA; Carlos L. Arteaga, MD, UT Southwestern Simmons Cancer Center, Dallas, TX; William F. Symmans, M
  • Flaum LE; Ingrid A. Mayer, MD, MSCI, Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Fengmin Zhao, PhD, Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA; Carlos L. Arteaga, MD, UT Southwestern Simmons Cancer Center, Dallas, TX; William F. Symmans, M
  • Mayer EL; Ingrid A. Mayer, MD, MSCI, Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Fengmin Zhao, PhD, Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA; Carlos L. Arteaga, MD, UT Southwestern Simmons Cancer Center, Dallas, TX; William F. Symmans, M
  • Sikov WM; Ingrid A. Mayer, MD, MSCI, Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Fengmin Zhao, PhD, Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA; Carlos L. Arteaga, MD, UT Southwestern Simmons Cancer Center, Dallas, TX; William F. Symmans, M
  • Rodler ET; Ingrid A. Mayer, MD, MSCI, Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Fengmin Zhao, PhD, Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA; Carlos L. Arteaga, MD, UT Southwestern Simmons Cancer Center, Dallas, TX; William F. Symmans, M
  • Wagner LI; Ingrid A. Mayer, MD, MSCI, Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Fengmin Zhao, PhD, Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA; Carlos L. Arteaga, MD, UT Southwestern Simmons Cancer Center, Dallas, TX; William F. Symmans, M
  • DeMichele AM; Ingrid A. Mayer, MD, MSCI, Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Fengmin Zhao, PhD, Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA; Carlos L. Arteaga, MD, UT Southwestern Simmons Cancer Center, Dallas, TX; William F. Symmans, M
  • Sparano JA; Ingrid A. Mayer, MD, MSCI, Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Fengmin Zhao, PhD, Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA; Carlos L. Arteaga, MD, UT Southwestern Simmons Cancer Center, Dallas, TX; William F. Symmans, M
  • Wolff AC; Ingrid A. Mayer, MD, MSCI, Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Fengmin Zhao, PhD, Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA; Carlos L. Arteaga, MD, UT Southwestern Simmons Cancer Center, Dallas, TX; William F. Symmans, M
  • Miller KD; Ingrid A. Mayer, MD, MSCI, Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN; Fengmin Zhao, PhD, Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA; Carlos L. Arteaga, MD, UT Southwestern Simmons Cancer Center, Dallas, TX; William F. Symmans, M
J Clin Oncol ; 39(31): 3522-3524, 2021 11 01.
Article em En | MEDLINE | ID: mdl-34554848
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article